146 related articles for article (PubMed ID: 34331765)
1. Bariatric Interventions in Craniopharyngioma Patients-Best Choice or Last Option for Treatment of Hypothalamic Obesity?
Müller HL
J Clin Endocrinol Metab; 2022 Jan; 107(1):e426-e428. PubMed ID: 34331765
[No Abstract] [Full Text] [Related]
2. Bariatric surgery for hypothalamic obesity in patients with craniopharyngioma: A literature review.
Hu HZ; Lei L
Asian J Surg; 2023 Dec; 46(12):5479. PubMed ID: 37537035
[No Abstract] [Full Text] [Related]
3. Is bariatric surgery really inefficient in hypothalamic obesity?
Gatta B; Nunes ML; Bailacq-Auder C; Etchechoury L; Collet D; Tabarin A
Clin Endocrinol (Oxf); 2013 Apr; 78(4):636-8. PubMed ID: 22994633
[No Abstract] [Full Text] [Related]
4. Liraglutide 3mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma.
Bretault M; Carette C; Zaharia R; Vychnevskaia K; Bouillot JL; Czernichow S; Raffin-Sanson ML
Diabetes Metab; 2020 Nov; 46(6):514-515. PubMed ID: 31362076
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-up.
Wijnen M; Olsson DS; van den Heuvel-Eibrink MM; Wallenius V; Janssen JA; Delhanty PJ; van der Lely AJ; Johannsson G; Neggers SJ
Int J Obes (Lond); 2017 Feb; 41(2):210-216. PubMed ID: 27795552
[TBL] [Abstract][Full Text] [Related]
6. For Debate: Should Bariatric Surgery be Performed in Children and Adolescents with Hypothalamic Obesity?
Stolbova S; Benes M; Petruzelkova L; Lebl J; Kolouskova S
Pediatr Endocrinol Rev; 2017 Jun; 14(4):348-352. PubMed ID: 28613044
[TBL] [Abstract][Full Text] [Related]
7. Postprandial GLP-1 Secretion After Bariatric Surgery in Three Cases of Severe Obesity Related to Craniopharyngiomas.
Bretault M; Laroche S; Lacorte JM; Barsamian C; Polak M; Raffin-Sanson ML; Touraine P; Bouillot JL; Czernichow S; Carette C
Obes Surg; 2016 May; 26(5):1133-7. PubMed ID: 26922186
[TBL] [Abstract][Full Text] [Related]
8. Bariatric Surgery for Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy: a Matched Case-Control Study.
Garrez I; Lapauw B; Van Nieuwenhove Y
Obes Surg; 2020 Jun; 30(6):2439-2444. PubMed ID: 31955372
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Hypothalamic Obesity in Patients With Adult-Onset Craniopharyngioma: A Consecutive Series of 120 Cases.
Wu W; Sun Q; Zhu X; Xiang B; Zhang Q; Miao Q; Wang Y; Li Y; Ye H
Front Endocrinol (Lausanne); 2021; 12():694213. PubMed ID: 34394000
[TBL] [Abstract][Full Text] [Related]
10. Management of Hypothalamic Obesity.
Müller HL
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):533-552. PubMed ID: 32741487
[TBL] [Abstract][Full Text] [Related]
11. Craniopharyngiomas: a life-changing tumor.
Mortini P
Endocrine; 2017 Aug; 57(2):191-192. PubMed ID: 27981519
[No Abstract] [Full Text] [Related]
12. Approach to the Patient With Hypothalamic Obesity.
Shoemaker AH; Tamaroff J
J Clin Endocrinol Metab; 2023 Apr; 108(5):1236-1242. PubMed ID: 36413492
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic obesity.
Babcock Gilbert S; Roth LW
Minerva Endocrinol; 2015 Mar; 40(1):61-70. PubMed ID: 25370939
[TBL] [Abstract][Full Text] [Related]
14. Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma.
Rottembourg D; O'Gorman CS; Urbach S; Garneau PY; Langer JC; Van Vliet G; Hamilton J; Huot C
J Pediatr Endocrinol Metab; 2009 Sep; 22(9):867-72. PubMed ID: 19960898
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin and Naltrexone Successfully Treat Hypothalamic Obesity in a Boy Post-Craniopharyngioma Resection.
Hsu EA; Miller JL; Perez FA; Roth CL
J Clin Endocrinol Metab; 2018 Feb; 103(2):370-375. PubMed ID: 29220529
[TBL] [Abstract][Full Text] [Related]
16. Interventions for the Treatment of Craniopharyngioma-Related Hypothalamic Obesity: A Systematic Review.
Ni W; Shi X
World Neurosurg; 2018 Oct; 118():e59-e71. PubMed ID: 29945001
[TBL] [Abstract][Full Text] [Related]
17. Postoperative hypothalamic damage predicts postoperative weight gain in patients with adult-onset craniopharyngioma.
Wu J; Fu J; Huang ZJ; Xie SH; Tang B; Wu X; Tong ZG; Wu BW; Pan CB; Yang YQ; Ding H; Li SY; Qi JL; Hong T
Obesity (Silver Spring); 2022 Jul; 30(7):1357-1369. PubMed ID: 35707874
[TBL] [Abstract][Full Text] [Related]
18. Pituitary hyposecretion and hypersecretion produced by a Rathke's cleft cyst presenting as a noncystic hypothalamic mass.
Wenzel M; Salcman M; Kristt DA; Gellad FE; Kapcala LP
Neurosurgery; 1989 Mar; 24(3):424-8. PubMed ID: 2494564
[TBL] [Abstract][Full Text] [Related]
19. Craniopharyngioma and hypothalamic obesity in children.
Vinchon M; Weill J; Delestret I; Dhellemmes P
Childs Nerv Syst; 2009 Mar; 25(3):347-52. PubMed ID: 19057910
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic obesity in a patient with craniopharyngioma: dysregulation of neurohormonal control of energy balance.
Maniatis AK; Simmons JH; Zeitler PS
Curr Opin Pediatr; 2005 Apr; 17(2):275-9. PubMed ID: 15800425
[No Abstract] [Full Text] [Related]
[Next] [New Search]
